Literature DB >> 11553379

The ACVD task force on canine atopic dermatitis (V): biology and role of inflammatory cells in cutaneous allergic reactions.

P B Hill1, T Olivry.   

Abstract

Numerous inflammatory cells are thought to play a role in the pathogenesis of canine atopic dermatitis (AD) although, in the past, mast cells were considered the most important. However, evidence for this assumption is lacking. In this paper, we review the literature concerning the role of inflammatory cells in allergic reactions and conclude that a complex interplay exists between a wide variety of cell types. Thus, on the basis of the available evidence, the cells that appear to be the most important in the pathogenesis of canine AD are Langerhans' cells and dermal dendritic cells (both responsible for antigen processing and presentation), B-lymphocytes (responsible for reaginic antibody production), allergen-specific helper T-lymphocytes (responsible for cytokine production leading to activation of B-cells and other inflammatory cells) and mast cells (production of inflammatory mediators leading to inflammation).

Entities:  

Mesh:

Year:  2001        PMID: 11553379     DOI: 10.1016/s0165-2427(01)00310-5

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

1.  Atopic dermatitis in West Highland white terriers is associated with a 1.3-Mb region on CFA 17.

Authors:  Joana B Roque; Caroline A O'Leary; David L Duffy; Myat Kyaw-Tanner; Puya Gharahkhani; Linda Vogelnest; Kenneth Mason; Michael Shipstone; Melanie Latter
Journal:  Immunogenetics       Date:  2011-10-12       Impact factor: 2.846

2.  Canine epidermal langerhans cells express alpha and gamma but not beta chains of high-affinity IgE receptor.

Authors:  M Bonkobara; F Miyake; H Yagihara; O Yamada; D Azakami; T Washizu; P D Cruz; K Ariizumi
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

3.  Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: a single-blinded, placebo-controlled study.

Authors:  Christopher P Cook; Danny W Scott; William H Miller; J Edward Kirker; Shaun M Cobb
Journal:  Can Vet J       Date:  2004-05       Impact factor: 1.008

4.  Masitinib for the treatment of canine atopic dermatitis: a pilot study.

Authors:  Jenise Daigle; Alain Moussy; Colin D Mansfield; Olivier Hermine
Journal:  Vet Res Commun       Date:  2009-12-23       Impact factor: 2.459

5.  PTPN22 polymorphisms may indicate a role for this gene in atopic dermatitis in West Highland white terriers.

Authors:  Joana Barros Roque; Caroline A O'Leary; Myat Kyaw-Tanner; David L Duffy; Puya Gharahkhani; Linda Vogelnest; Kenneth Mason; Michael Shipstone
Journal:  BMC Res Notes       Date:  2011-12-30

6.  Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial.

Authors:  M Eichenseer; C Johansen; R S Mueller
Journal:  Vet Rec       Date:  2013-10-10       Impact factor: 2.695

7.  Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.

Authors:  Susanne Gamperl; Gabriele Stefanzl; Barbara Peter; Dubravka Smiljkovic; Karin Bauer; Michael Willmann; Peter Valent; Emir Hadzijusufovic
Journal:  Vet Comp Oncol       Date:  2019-08-13       Impact factor: 2.613

8.  Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis.

Authors:  Roberto Chiocchetti; Giulia Salamanca; Margherita De Silva; Francesca Gobbo; Francesca Aspidi; Rodrigo Zamith Cunha; Giorgia Galiazzo; Claudio Tagliavia; Giuseppe Sarli; Maria Morini
Journal:  Front Vet Sci       Date:  2022-09-15

9.  Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma.

Authors:  Cindy L Zuleger; Chulhi Kang; Erik A Ranheim; Ilene D Kurzman; Michael D Macklin; Michael A Newton; Jedd D Wolchok; David M Vail; Elof Eriksson; Mark R Albertini
Journal:  Vet Med Sci       Date:  2017-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.